BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rees O, Agarwal SK. Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media. Clin Radiol 2010;65:636-41. [PMID: 20599066 DOI: 10.1016/j.crad.2010.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Tamburrini O, Balducci A. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced? Radiol med 2012;117:1-5. [DOI: 10.1007/s11547-011-0737-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, Nagel E, Bauer WR. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:31. [PMID: 22607376 DOI: 10.1186/1532-429X-14-31] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
3 Rasschaert M, Idée JM, Robert P, Fretellier N, Vives V, Violas X, Ballet S, Corot C. Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats. Invest Radiol 2017;52:255-64. [PMID: 28067754 DOI: 10.1097/RLI.0000000000000339] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
4 Weller A, Barber JL, Olsen ØE. Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol 2014;29:1927-37. [DOI: 10.1007/s00467-013-2636-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
5 Shen AJ, Li DL, Cai XJ, Dong CY, Dong HQ, Wen HY, Dai GH, Wang PJ, Li YY. Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J Biomed Mater Res A 2012;100:2499-506. [PMID: 22623284 DOI: 10.1002/jbm.a.34148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
6 Mouraviev V, Venkatraman TN, Tovmasyan A, Kimura M, Tsivian M, Mouravieva V, Polascik TJ, Wang H, Amrhein TJ, Batinic-Haberle I, Lascola C. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents. J Endourol 2012;26:1420-4. [PMID: 22783812 DOI: 10.1089/end.2012.0171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
7 Mouraviev V, Venkatraman TN, Tovmasyan A, Kimura M, Tsivian M, Mouravieva V, Polascik TJ, Wang H, Amrhein TJ, Batinic-Haberle I, Lascola C. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents. J Endourol 2011;:1420-4. [PMID: 22050509 DOI: 10.1089/end.2011.0133] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Piersson AD, Gorleku PN. Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana. Radiography (Lond) 2017;23:e108-13. [PMID: 28965904 DOI: 10.1016/j.radi.2017.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Algin O, Ozmen E, Metin MR, Ozcan MF, Sivaslioglu AA, Karaoglanoglu M. Contrast-material-enhanced MR urography in evaluation of postoperative lower urinary tract fistulae and leakages. Magn Reson Imaging 2012;30:734-9. [PMID: 22459436 DOI: 10.1016/j.mri.2011.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Niemann AK, Thrysoe S, Nygaard JV, Hasenkam JM, Petersen SE. Computational Fluid Dynamics Simulation of a-v Fistulas: From MRI and Ultrasound Scans to Numeric Evaluation of Hemodynamics. J Vasc Access 2012;13:36-44. [DOI: 10.5301/jva.2011.8440] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]